El Salvador Sets Up New Regulatory Body To Oversee Medicines & Devices

El Salvador has approved a new law that will establish a new regulatory body responsible for authorizing medicines and setting prices.

El Salvador flag pinned to map.
El Salvador Strengthens Regulatory environment for medicines • Source: Shutterstock

El Salvador is to create the Superintendency for Health Regulation (SHR), a new regulatory body that will authorize medicines and medical devices, grant export and import licenses and set medicine prices. The move is expected to strengthen the national health system and protect patients, as well as make El Salvador a more competitive pharmaceutical market.

Earlier this month, the country’s legislative assembly passed the Health Regulation Superintendency bill, which will establish the new entity

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Latin America

China Strikes Back After Trump Ups Tariffs; Administration Further Delays Tariffs On Canada And Mexico

 

In response to the Trump administration increasing its tariffs on imports from China, Beijing announced a ban on gene sequencers from US biotech firm Illumina, signaling a full-blown trade war could be in the making. Trump also pushed the deadline for implementing tariffs on Canada and Mexico back by another month.

PathAI Enters South American Market Partnering With Integrated Healthcare Network Rede D’or

 

PathAI, a Boston-based AI-pathology startup backed by $355m, partners with Brazil’s largest integrated healthcare network to support diagnosis and treatment of cancer patients using its AISight image management system.

Could A Wider Trade War Be Brewing? Beijing Retaliates With Own Tariffs While AdvaMed Asks Administration For Exemption

 

Concerns President Trump’s tariffs could create a full-blown trade war with China jumped dramatically as Beijing responded with its own set of tariffs targeting various US goods. On the medtech front, AdvaMed wants Trump to create a carve-out for Chinese medical devices as he did in his first term.

El Salvador Sets Up New Regulatory Body To Oversee Medicines & Devices

 

El Salvador has approved a new law that will establish a new regulatory body responsible for authorizing medicines and setting prices.

More from Geography

Does Makary’s Reorg Choice Mark FDA Turning Point?

 

US FDA Commissioner Martin Makary’s disavowal of a proposed reorganization plan may be an important turning point in the Trump Administration. The move does not improve the situation, but may mean the administration stops actively making things worse.

MedTech Europe’s Bisazza Urges Action As US Tariffs Jeopardize Critical Global Supply Chains

 

The intricate assembly of medical devices, often involving over 1,000 globally sourced components, faces severe disruption due to new US tariffs. These barriers could halt production and devastate small and medium-sized enterprises (SMEs), MedTech Europe’s CEO, Oliver Bisazza, warns in an interview with Medtech Insight.

Don’t Sleep On Inspections: Experts Warn FDA Maintains Enforcement Resources

 

Manufacturers of medical products would be foolish to think that recent upheavals at the US FDA will result in a lack of inspections in the coming years. A panel of experts discussed the current state of inspections during a webinar hosted by the Food and Drug Law Institute.